Literature DB >> 16238192

Genomic and non-genomic regulation of L-type calcium channels in rat ventricle by thyroid hormone.

Hiroshi Watanabe1, Takashi Washizuka, Satoru Komura, Tsuyoshi Yoshida, Yukio Hosaka, Katsuharu Hatada, Yoshifusa Aizawa, Masaomi Chinushi, Tadashi Yamamoto, Meilei Ma, Kenichi Watanabe.   

Abstract

Hyperthyroidism is associated with low exercise tolerance despite high cardiac output and sometimes with the development of heart failure. L-type calcium channels may play a role in the mechanism, but this has not been fully understood. We examined the effects of thyroid hormone on gene expression and function of L-type calcium channels in rat ventricles by the ribonuclease protection assay and whole-cell patch-clamp technique, respectively. The effects of bisoprolol, beta-blocking agent, on the regulation of calcium channel by thyroid hormone was also studied. In hyperthyroid animals, the mRNA of the calcium channel alpha1c subunit was reduced on day 4, compared with that in euthyroid animals, and remained low on day 8. Bisoprolol did not affect the thyroid hormone mediated decrease in alpha1c subunit mRNA. While L-type calcium current was greater in hyperthyroid than euthyroid myocytes on day 4, it was smaller on day 8. In addition, the isoproterenol-induced increase in calcium current in euthyroid rats was attenuated in hyperthyroid rats. Acetylcholine decreased calcium current in hyperthyroid myocytes, but not in euthyroid myocytes. In conclusion, L-type calcium current was increased by thyroid hormone in rat ventricular myocytes by the activation of the adenylate cyclase cascade, despite a decreased calcium channel gene expression. These genomic and non-genomic modifications may play an important role in the association of high cardiac output with low exercise tolerance, and in the development of heart failure in hyperthyroidism.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16238192     DOI: 10.1080/07435800500229227

Source DB:  PubMed          Journal:  Endocr Res        ISSN: 0743-5800            Impact factor:   1.720


  6 in total

1.  Effects of angiotensin II blockade on inflammation-induced alterations of pharmacokinetics and pharmacodynamics of calcium channel blockers.

Authors:  S Hanafy; N J Dagenais; W F Dryden; F Jamali
Journal:  Br J Pharmacol       Date:  2007-10-29       Impact factor: 8.739

2.  Gestational hypothyroidism-induced changes in L-type calcium channels of rat aorta smooth muscle and their impact on the responses to vasoconstrictors.

Authors:  Katayoun Sedaghat; Saleh Zahediasl; Asghar Ghasemi
Journal:  Iran J Basic Med Sci       Date:  2015-02       Impact factor: 2.699

3.  Functional Effects of Hyperthyroidism on Cardiac Papillary Muscle in Rats.

Authors:  Fabricio Furtado Vieira; Robson Ruiz Olivoto; Priscyla Oliveira da Silva; Julio Cesar Francisco; Rosalvo Tadeu Hochmuller Fogaça
Journal:  Arq Bras Cardiol       Date:  2016-12       Impact factor: 2.000

Review 4.  Pro-Arrhythmic Signaling of Thyroid Hormones and Its Relevance in Subclinical Hyperthyroidism.

Authors:  Narcis Tribulova; Lin Hai Kurahara; Peter Hlivak; Katsuya Hirano; Barbara Szeiffova Bacova
Journal:  Int J Mol Sci       Date:  2020-04-19       Impact factor: 5.923

5.  High Thyrotropin Is Critical for Cardiac Electrical Remodeling and Arrhythmia Vulnerability in Hypothyroidism.

Authors:  Julieta Fernandez-Ruocco; Monica Gallego; Ainhoa Rodriguez-de-Yurre; Julian Zayas-Arrabal; Leyre Echeazarra; Amaia Alquiza; Victor Fernández-López; Juan M Rodriguez-Robledo; Oscar Brito; Ygor Schleier; Marisa Sepulveda; Natalia F Oshiyama; Martin Vila-Petroff; Rosana A Bassani; Emiliano H Medei; Oscar Casis
Journal:  Thyroid       Date:  2019-06-13       Impact factor: 6.568

Review 6.  Levothyroxine Treatment and the Risk of Cardiac Arrhythmias - Focus on the Patient Submitted to Thyroid Surgery.

Authors:  Zoran Gluvic; Milan Obradovic; Alan J Stewart; Magbubah Essack; Samantha J Pitt; Vladimir Samardzic; Sanja Soskic; Takashi Gojobori; Esma R Isenovic
Journal:  Front Endocrinol (Lausanne)       Date:  2021-11-04       Impact factor: 5.555

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.